01826nam a2200409 i 4500001001300000003000600013005001700019007001400036008004100050040003000091042000800121043001200129074001600141086002000157110007100177245013800248264007200386300002200458336000800480337001600488338001900504490007700523500002400600500003600624500002000660500002500680504004100705533010600746776014100852776014200993810005801135050002001193650004501213650006001258650006401318655003401382on1056193291OCoLC20181115094143.0he bmb024bbca181009s2018    dcu     bb   f000 0 eng c  aPUCPRbengerdacGPOdMvI  apcc  an-us---  a1008-D (MF)0 aY 1.1/8:115-6841 aUnited States.bCongress.bHouse.bCommittee on Veterans' Affairs,10aVeterans Opioid Abuse Prevention Act :breport (to accompany H.R. 3832) (including cost estimate of the Congressional Budget Office). 1a[Washington, D.C.] :b[U. S. Government Publishing Office],c[2018]  a11 pages ;c24 cm  btxt  bh2rdamedia  bhe2rdacarrier1 aReport / 115th Congress, 2d session, House of Representatives ;v115-684  aTitle from caption.  aShipping list no.: 2018-0170-M.  a"May 18, 2018."  aCRDP Program record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2018]e1 microfiche : negative.08iPrint version:aUnited States. Congress. House. Committee on Veterans' Affairs.tVeterans Opioid Abuse Prevention Actw(OCoLC)103727781208iOnline version:aUnited States. Congress. House. Committee on Veterans' Affairs.tVeterans Opioid Abuse Prevention Actw(OCoLC)10372775161 aUnited States.bCongress.bHouse.tReport ;v115-684. 4aKF32b.V4 2018a 0aOpioid abusezUnited StatesxPrevention. 0aDrugsxPrescribingxLaw and legislationzUnited States. 0aVeteransxMedical carexLaw and legislationzUnited States. 7aLegislative materials.2lcgft